Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity.

CONCLUSION: The tapering strategy in SpA results in an important reduction of the drug administered, and the disease control remains similar to that of the patients with SpA receiving the standard regimen. PMID: 26178279 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26178279?dopt=Abstract

Source: J Rheumatol - July 15, 2015 Category: Rheumatology Authors: Plasencia C, Kneepkens EL, Wolbink G, Krieckaert CL, Turk S, Navarro-Compán V, L'Ami M, Nurmohamed MT, van der Horst-Bruinsma I, Jurado T, Diego C, Bonilla G, Villalba A, Peiteado D, Nuño L, van der Kleij D, Rispens T, Martín-Mola E, Balsa A, Pascual-S Tags: J Rheumatol Source Type: research